SKLB 610
SKLB610 is a novel multi-targeted tyrosine kinase inhibitor. At 10 μM, it potently inhibits VEGFR2 (97%), FGFR2 (65%), and PDGFR (55%) in biochemical assays. This profile supports its research use in studying angiogenesis and tumor growth in both cellular and animal models.
Product Specifications
CAS Number
1125780-41-7
Product Name Alternative
PDGFR, FGFR, SKLB610, SKLB-610, SKLB 610, VEGFR
Field of Research
Cardiovascular Research, Signal Transduction
Purity
98.88% (May vary between batches)
Solubility
DMSO:50 mg/mL (120.37 mM)
Smiles
O (C=1C=C (C (NC) =O) N=CC1) C2=CC=C (NC (=O) C3=CC (C (F) (F) F) =CC=C3) C=C2
Molecular Formula
C21H16F3N3O3
Molecular Weight
415.37
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
138496-AF-PE 100 µL
BCL10 (MALT-Lymphoma Marker) (B Cell CLL/lymphoma 10, B Cell leukemia/lymphoma 10, CARD-containing molecule enhancing NF-kappa-B, CARD-like apoptotic protein, caspase-recruiting domain-containing protein, CED-3/ICH-1 prodomain homologous E10-like regulator, Cellular homolog of vCARMEN, Cellular-E10 (cE10), CIPER, hCLAP, mE10) (PE)
Sign In for Pricing
View Details 
NBP3-05987FR 0.1 mL
Rabbit Polyclonal EOGT/AER61 Antibody [DyLight 680]
Sign In for Pricing
View Details